Method Study: Bilateral TAP Block With 24 Hours Infusion

May 3, 2012 updated by: Pernille Lykke Petersen, Glostrup University Hospital, Copenhagen

Method Study of Bilateral Transversus Abdominis Plane (TAP) Block With 24 Hours Infusion. Extent of Sensory Block, Analgetic Effect and Lung Function in Healthy Volunteers

The purpose of this method study in healthy volunteers is to determine the extent of sensory block following Transversus Abdominis Plane (TAP) block with 24 hours infusion of ropivacaine versus infusion of saline. Furthermore, to determined the analgesic effect of the TAP block and the influence on the lung function.

Study Overview

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • HovedOrtoCentret, Rigshospitalet
      • Copenhagen, Denmark, 2100
        • HOC, anesthesiology, Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • age between 18 and 30 years
  • written consent
  • ASA 1
  • BMI between 18 and 25
  • males

Exclusion Criteria:

  • unable to communicate in Danish
  • relevant drug allergy
  • alcohol or/and drug abuse
  • daily intake of prescription pain medication the last 4 weeks
  • pain medication in the last 48 hours
  • previously operated abdominal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Infusion of local anesthetic
TAP block with 20 ml of ropivacaine 0,5%, catheter with infusion of ropivacaine 0,2% 5 ml/h 24 hours.
TAP block with ropivacaine 20 ml 0,5%. Catheter with infusion of ropivacaine 0,2% 5 ml/h 24 hours on one side of the abdomen.
Placebo Comparator: Infusion of saline
TAP block with 20 ml of ropivacaine 0,5%, catheter with infusion of saline 5 ml/h 24 hours.
TAP block with ropivacaine 0,5% 20 ml. Catheter with infusion of saline 5 ml/h 24 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in extend of sensory block from baseline (pre block) to 24 hours post block, based on 6 measurements
Time Frame: -15 min., 1, 4, 8, 12 and 24 hours following TAP block
Extent of sensory block using pinprick and ice
-15 min., 1, 4, 8, 12 and 24 hours following TAP block

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heat pain detection threshold (abdomen)
Time Frame: -15 min., 1, 4, 8, 12 and 24 hours following TAP block
Gradually heating of the skin from 32 to 52 degrees Celcius. The participant indicates the temperature where the stimulus is painful.
-15 min., 1, 4, 8, 12 and 24 hours following TAP block
Heat pain detection threshold (dominant forearm)
Time Frame: -15 min., 1, 4, 8, 12 and 24 hours following TAP block
Gradually heating of the skin from 32 to 52 degrees Celcius. The participant indicates the temperature where the stimulus is painful.
-15 min., 1, 4, 8, 12 and 24 hours following TAP block
Long Thermal stimulation (abdomen)
Time Frame: -15 min., 1, 4, 8, 12 and 24 hours following TAP block
Heating of the skin, 45 degrees Celsius 1 minute. The participant indicates pain scores on a Visuel Analog Scale from 0 (no pain) to 100 (worst imaginable)
-15 min., 1, 4, 8, 12 and 24 hours following TAP block
Lung function
Time Frame: -15 min., 1, 4, 8, 12 and 24 hours following TAP block
Inspiratory and expiratory force
-15 min., 1, 4, 8, 12 and 24 hours following TAP block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pernille L Petersen, MD, HOC, anesthesiology, Rigshospitalet, Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

November 21, 2011

First Submitted That Met QC Criteria

April 13, 2012

First Posted (Estimate)

April 16, 2012

Study Record Updates

Last Update Posted (Estimate)

May 4, 2012

Last Update Submitted That Met QC Criteria

May 3, 2012

Last Verified

May 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Infusion of ropivacaine

Subscribe